Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima, Japan.
Syst Biol Reprod Med. 2012 Oct;58(5):278-87. doi: 10.3109/19396368.2012.688088. Epub 2012 May 28.
The aim of this study was to investigate whether direct injection of nonviral DNA into the oviductal lumen and subsequent in vivo electroporation leads to in vivo gene transfer in mouse preimplantation embryos present within an oviduct, as an alternative to the pre-existing pronuclear microinjection-based transgenesis. With this technique, effects of expression of the gene of interest (GOI) on mouse preimplantation development can be monitored with relative ease. Superovulated 4-week-old B6C3F1 female mice (hybrids between C57BL/6N and C3H/HeN) were mated with adult B6C3F1 male mice. Two days later, females that had been identified as pregnant, based on the presence of copulation plugs, were injected with 1 µl of a solution containing an enhanced green fluorescent protein (EGFP) expression plasmid (0.5 µg) and 0.05% trypan blue. The entire oviduct was then electroporated using tweezer-type electrodes with 8 square-wave pulses of 50 V each with 50-ms duration. The next day, the 8-cell stage embryos were collected, and their number, morphology, and EGFP-derived fluorescence were recorded. Of the 12 oviducts (6 females used) examined, 3 contained fluorescent 8-cell stage embryos (33%, 19/58 tested), but the intensity of fluorescence varied among the embryos. In total, 10% (19/192 tested) of the embryos were fluorescent and the fluorescence was maintained in these embryos after 1 day of culture. However, the fluorescence disappeared in the late gestational stage fetuses, and the transgenes could not be detected. Our results indicate that it is possible to transfect in vivo preimplantation embryos, although the success rate appears to be relatively low and gene expression is transient. This technology may provide a new method for manipulating preimplantation embryos in vivo, by using, for example, Cre-mediated conditional DNA recombination.
本研究旨在探讨将非病毒 DNA 直接注入输卵管腔并随后进行体内电穿孔是否会导致输卵管内的小鼠着床前胚胎发生体内基因转移,以此替代现有的基于原核显微注射的转基因技术。使用这种技术,可以相对容易地监测目的基因(GOI)表达对小鼠着床前发育的影响。对 4 周龄超排卵的 B6C3F1 雌性小鼠(C57BL/6N 和 C3H/HeN 的杂交种)进行交配,与成年 B6C3F1 雄性小鼠交配。两天后,根据交配栓的存在确定怀孕的雌性小鼠,然后向其输卵管内注射 1μl 含有增强型绿色荧光蛋白(EGFP)表达质粒(0.5μg)和 0.05%台盼蓝的溶液。然后使用镊子型电极对整个输卵管进行电穿孔,每个电极施加 8 个 50V 的方波脉冲,持续 50ms。第二天,收集 8 细胞期胚胎,并记录其数量、形态和 EGFP 衍生的荧光。在检查的 12 个输卵管(6 只雌性)中,有 3 个含有荧光 8 细胞期胚胎(33%,19/58 个测试),但胚胎之间的荧光强度存在差异。总共 10%(19/192 个测试)的胚胎具有荧光,并且这些胚胎在培养 1 天后荧光仍然存在。然而,荧光在晚期妊娠胎儿中消失,并且无法检测到转基因。我们的结果表明,虽然成功率似乎相对较低且基因表达是短暂的,但可以对体内着床前胚胎进行转染。该技术可能为体内操作着床前胚胎提供一种新方法,例如使用 Cre 介导的条件性 DNA 重组。